Cargando…
A Guide to In Silico Drug Design
The drug discovery process is a rocky path that is full of challenges, with the result that very few candidates progress from hit compound to a commercially available product, often due to factors, such as poor binding affinity, off-target effects, or physicochemical properties, such as solubility o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867171/ https://www.ncbi.nlm.nih.gov/pubmed/36678678 http://dx.doi.org/10.3390/pharmaceutics15010049 |
_version_ | 1784876276138377216 |
---|---|
author | Chang, Yiqun Hawkins, Bryson A. Du, Jonathan J. Groundwater, Paul W. Hibbs, David E. Lai, Felcia |
author_facet | Chang, Yiqun Hawkins, Bryson A. Du, Jonathan J. Groundwater, Paul W. Hibbs, David E. Lai, Felcia |
author_sort | Chang, Yiqun |
collection | PubMed |
description | The drug discovery process is a rocky path that is full of challenges, with the result that very few candidates progress from hit compound to a commercially available product, often due to factors, such as poor binding affinity, off-target effects, or physicochemical properties, such as solubility or stability. This process is further complicated by high research and development costs and time requirements. It is thus important to optimise every step of the process in order to maximise the chances of success. As a result of the recent advancements in computer power and technology, computer-aided drug design (CADD) has become an integral part of modern drug discovery to guide and accelerate the process. In this review, we present an overview of the important CADD methods and applications, such as in silico structure prediction, refinement, modelling and target validation, that are commonly used in this area. |
format | Online Article Text |
id | pubmed-9867171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98671712023-01-22 A Guide to In Silico Drug Design Chang, Yiqun Hawkins, Bryson A. Du, Jonathan J. Groundwater, Paul W. Hibbs, David E. Lai, Felcia Pharmaceutics Review The drug discovery process is a rocky path that is full of challenges, with the result that very few candidates progress from hit compound to a commercially available product, often due to factors, such as poor binding affinity, off-target effects, or physicochemical properties, such as solubility or stability. This process is further complicated by high research and development costs and time requirements. It is thus important to optimise every step of the process in order to maximise the chances of success. As a result of the recent advancements in computer power and technology, computer-aided drug design (CADD) has become an integral part of modern drug discovery to guide and accelerate the process. In this review, we present an overview of the important CADD methods and applications, such as in silico structure prediction, refinement, modelling and target validation, that are commonly used in this area. MDPI 2022-12-23 /pmc/articles/PMC9867171/ /pubmed/36678678 http://dx.doi.org/10.3390/pharmaceutics15010049 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Chang, Yiqun Hawkins, Bryson A. Du, Jonathan J. Groundwater, Paul W. Hibbs, David E. Lai, Felcia A Guide to In Silico Drug Design |
title | A Guide to In Silico Drug Design |
title_full | A Guide to In Silico Drug Design |
title_fullStr | A Guide to In Silico Drug Design |
title_full_unstemmed | A Guide to In Silico Drug Design |
title_short | A Guide to In Silico Drug Design |
title_sort | guide to in silico drug design |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867171/ https://www.ncbi.nlm.nih.gov/pubmed/36678678 http://dx.doi.org/10.3390/pharmaceutics15010049 |
work_keys_str_mv | AT changyiqun aguidetoinsilicodrugdesign AT hawkinsbrysona aguidetoinsilicodrugdesign AT dujonathanj aguidetoinsilicodrugdesign AT groundwaterpaulw aguidetoinsilicodrugdesign AT hibbsdavide aguidetoinsilicodrugdesign AT laifelcia aguidetoinsilicodrugdesign AT changyiqun guidetoinsilicodrugdesign AT hawkinsbrysona guidetoinsilicodrugdesign AT dujonathanj guidetoinsilicodrugdesign AT groundwaterpaulw guidetoinsilicodrugdesign AT hibbsdavide guidetoinsilicodrugdesign AT laifelcia guidetoinsilicodrugdesign |